Chris Savile
About Chris Savile
Dr. Chris Savile is an accomplished scientist and executive with 17 years of experience in biotech, specializing in the scale-up and commercialization of biobased processes across various industries.
Company
Dr. Chris Savile serves as the CEO, President, and Director at his current company, Willow. Willow operates in the biotech sector, focusing on innovative biobased processes to serve industries such as pharmaceuticals, food & beverage, and energy. Under Dr. Savile's leadership, Willow aims to scale up and commercialize these advanced biotechnological developments, leveraging his extensive experience in the field.
Education and Expertise
Dr. Chris Savile obtained his PhD in Organic Chemistry from McGill University in 2005. With a career spanning 17 years, he has established himself as a highly experienced scientist and operations expert. His work focuses on scaling up and commercializing biobased processes, particularly in the pharma, food & beverage, and energy sectors. Dr. Savile's expertise is recognized through his technical leadership and role as a commercial program manager on several large R&D programs.
Background in Biotechnology
Dr. Chris Savile has held significant roles in leading biotech companies such as Codexis, Zymergen, and Intrexon before he joined Willow. His background in these organizations involved various science, commercial, and operations roles, each contributing to his in-depth knowledge and skill set in biotechnology. His work has consistently focused on driving innovation in biobased processes and transformative chemistries.
Achievements and Publications
Throughout his career, Dr. Chris Savile has contributed over 25 articles, book chapters, and patents related to the development of biobased processes. His published works emphasize transformative chemistries and challenging-to-synthesize products, reflecting his deep expertise and commitment to advancing biotechnological research. These publications have had a significant impact on the field and showcase his contributions to science and technology.